Live Breaking News & Updates on Wake disorders center

Stay informed with the latest breaking news from Wake disorders center on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Wake disorders center and stay connected to the pulse of your community

Is Your Fatigue More than Lack of Sleep? UAB Experts Discuss Sleep Apnea

Is Your Fatigue More than Lack of Sleep? UAB Experts Discuss Sleep Apnea
birminghamtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from birminghamtimes.com Daily Mail and Mail on Sunday newspapers.

United-states , Brian-kinard , Patricia-patterson , Centers-for-disease , Blood-institute , National-council-on , University-of-alabama-at-birminghamschool-dentistry , Wake-disorders-center , National-heart , Disease-control , National-council , Racial-differences

Is your fatigue more than your lack of sleep? UAB experts discuss sleep apnea

UAB experts says that individuals can prevent or decrease symptoms of sleep apnea by making small lifestyle changes. Written by: Katherine KirkMedia contact: Anna Jones UAB experts says that individuals can prevent or de...

United-states , Patricia-patterson , Brian-kinard , Anna-jones , Katherine-kirk , Centers-for-disease , Blood-institute , National-council-on , Wake-disorders-center , National-heart , University-of-alabama-at-birminghamschool-dentistry , Disease-control

Psychiatry in the News: March 2024

Here are some updates from the world of psychiatry throughout the month of March.

Johnj-miller , Michael-thorpy , Pimavanserin-nuplazid , Drug-administration , Albert-einstein-college-of-medicine , Wake-disorders-center , Acadia-pharmaceuticals , Montefiore-medical-center , Psychiatric-times , Narcolepsy-meets-primary , Orphan-drug-designation , Sleep-wake-disorders-center

Phase 3 Trial of AXS-12 for Narcolepsy Meets Primary Endpoint

The treatment significantly reduced the frequency of cataplexy attacks in patients with narcolepsy compared with placebo.

Herriot-tabuteau , Michael-thorpy , Wake-disorders-center , Albert-einstein-college-of-medicine , Montefiore-medical-center , Orphan-drug-designation , Sleep-wake-disorders-center , Albert-einstein-college , Axsome-therapeutics , Accessed-march ,

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

AXS-12 statistically significantly reduced cataplexy attacks compared to placebo AXS-12 achieved statistically significant remission of cataplexy compared to placebo AXS-12 statistically...

New-york , United-states , Mark-jacobson , Darren-opland , Michael-thorpy , Axsome-therapeutics-inc , Nasdaq , Wake-disorders-center , Corporate-communications , Drug-administration , World-trade-center , Montefiore-medical-center

Axsome Therapeutics Announces New SYMPHONY, CRESCENDO Data in Narcolepsy

The SYMPHONY trial found reboxetine can significantly reduce cataplexy, excessive daytime sleepiness, cognitive impairment, depression, and anxiety for patients with narcolepsy.

Herriot-tabuteau , Michael-thorpy , Wake-disorders-center , Montefiore-medical-center , Drug-administration , Sleep-wake-disorders-center , Albert-einstein-college , Epworth-sleepiness-scale , Epworth-sleepiness , Orphan-drug-designation , Axsome-therapeutics ,

AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial

Axsome Therapeutics announced topline trial results, which show AXS-12 significantly improves key narcolepsy symptoms.

Michael-thorpy , Herriot-tabuteau , Albert-einstein-college-of-medicine , Montefiore-medical-center , Wake-disorders-center , Axsome-therapeutics , Axsome-therapeutic , Clinician-global-impression , Narcolepsy-symptom-assessment , Epworth-sleepiness-scale , Cognitive-function-items

Addressing the Burden of Cardiovascular Comorbidities in Narcolepsy: Strategies and Perspectives to Optimize Treatment and Patient Outcomes

Addressing the Burden of Cardiovascular Comorbidities in Narcolepsy: Strategies and Perspectives to Optimize Treatment and Patient Outcomes
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Michaelj-thorpy , Virendk-somers , Richardk-bogan , Jazz-pharmaceuticals-inc , Montefiore-medical-center , Wake-disorders-center , Program-overview , Accreditation-council-for-continuing-medical-education , Cardiometabolic-health-congress

Narcolepsy Drug Candidate Promising But Raises Liver Concerns

In narcolepsy patients, TAK-994 showed significant improvements in wakefulness and reduced cataplexy rates but had hepatotoxic effects.

France , Yves-dauvilliers , Sarah-sheikh , Wake-disorders-center , New-england-journal , Sleep-wake-disorders-center , Gui-de-chauliac-hospital , Wakefulness-test , Epworth-sleepiness-scale , Epworth-sleepiness ,

Takeda Pharmaceutical (TAK) Reports Publication of Data from Phase 2 Study of TAK-994

Takeda Pharmaceutical (TAK) Reports Publication of Data from Phase 2 Study of TAK-994
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France , Yves-dauvilliers , Department-of-neurology , Wake-disorders-center , New-england-journal , Orexin-receptor , Narcolepsy-type , Sleep-wake-disorders-center , Gui-de-chauliac-hospital , Wakefulness-test , Epworth-sleepiness-scale , Efficacy-results